<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6810993/results/search/test_trace/results.xml">
  <result pre="that the work is properly cited. For commercial re-use, please" exact="contact" post="journals.permissions@oup.comofz360.372.pdf Abstract Abstract Background To achieve hepatitis C elimination,"/>
  <result pre="contact journals.permissions@oup.comofz360.372.pdf Abstract Abstract Background To achieve hepatitis C elimination," exact="treatment" post="programs need to be developed to engage, treat, and"/>
  <result pre="linked to HCV care (defined as one visit with HCV" exact="treatment" post="provider), and initiated direct-acting antiviral (DAA) treatment within 6"/>
  <result pre="visit with HCV treatment provider), and initiated direct-acting antiviral (DAA)" exact="treatment" post="within 6 months of enrollment. Results Among the 65"/>
  <result pre="started on DAA therapy, the median time from enrollment to" exact="treatment" post="initiation was 87.5 days [range 22â€“180]. Conclusion Among HCV-infected"/>
  <result pre="syringe service program, higher rates of linkage to care and" exact="treatment" post="initiation were seen in the Accessible Care arm where"/>
  <result pre="seen in the Accessible Care arm where stigma- and shame-free" exact="treatment" post="was located within a community-based location. Disclosures All authors:"/>
 </snippets>
</snippetsTree>
